BC-1382
BC-1382 is a potent ubiquitin E3 ligase HECTD2 inhibitor that specificly disrupts the HECTD2/PIAS1 interaction (IC50≈ 5 nM) .Anti-inflammatory activity[1].
Product Specifications
CAS Number
[1013753-99-5]
UNSPSC
12352005
Hazard Statement
H302-H312-H315-H319-H332-H335
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bc-1382.html
Purity
99.53
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1CCN(S(=O)(C2=CC=CC=C2)=O)CC1)N[C@@H](C)C(NCC3=CC=CC=C3OC)=O
Molecular Formula
C23H29N3O5S
Molecular Weight
459.56
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362-P403+P233-P405-P501
References & Citations
[1]Tiffany A Coon, et al. The proinflammatory role of HECTD2 in innate immunity and experimental lung injury. Sci Transl Med. 2015 Jul 8;7 (295) :295ra109.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6361114-01 0.2 mL
UGCGL1, CT (UGGT1, GT, UGCGL1, UGGT, UGT1, UGTR, UDP-glucose:glycoprotein glucosyltransferase 1, UDP-Glc:glycoprotein glucosyltransferase, UDP-glucose ceramide glucosyltransferase-like 1) (APC)
Ask
View Details MBS6361114-02 5x 0.2 mL
UGCGL1, CT (UGGT1, GT, UGCGL1, UGGT, UGT1, UGTR, UDP-glucose:glycoprotein glucosyltransferase 1, UDP-Glc:glycoprotein glucosyltransferase, UDP-glucose ceramide glucosyltransferase-like 1) (APC)
Ask
View Details